Top Key Market Drivers: Prenatal Testing Market
- Increase in Down Syndrome
The prevalence of Down syndrome, recognized as the leading chromosomal condition in the U.S. according to the Centers for Disease Control and Prevention in 2023, significantly influences the prenatal testing market. The CDC reports that roughly 6,000 infants born in the U.S. annually are identified with Down syndrome, corresponding to an occurrence rate of approximately one in every 700.
- Increase in Rare Genetic Disorders
The rise in awareness and understanding of rare genetic disorders has become a significant catalyst for the surge in prenatal testing. Expectant parents are increasingly seeking comprehensive genetic screenings to identify potential rare genetic disorders early in pregnancy.
The term “advanced maternal age” is applied to individuals aged 35 years or older during pregnancy, and pregnancies in this age group are associated with higher complication risks, including higher rates of miscarriage, genetic disorders, and diminished egg quality. As age increases, egg quality decreases, and older eggs are more likely to cause chromosomal anomalies, many of which are screened for during the first trimester.
The growing trend of delaying childbirth has become a key driver for the prenatal testing market, influencing its expansion. This shift, mainly observed in older mothers, is linked to an increased risk of chromosomal abnormalities.
Which region has the highest market share in prenatal testing market? – Its North America
A well-established healthcare infrastructure, high awareness levels regarding prenatal screening, favorable reimbursement policies and technological advancements characterize the North American market for prenatal testing. Factors such as a higher prevalence of genetic disorders, increasing maternal age and a proactive approach toward healthcare contribute to the growth of the prenatal testing market in North America.
The region’s ongoing research and development activities also drive innovation in prenatal testing technologies and contribute to market expansion. The North American market for prenatal testing is anticipated to grow at a CAGR of 13.1%, reaching $9.5 billion by the end of 2028, with a market share of 46.8% in 2022.
Future Market Prediction
The predominant factor driving the market growth is the increasing prevalence of chromosome abnormalities, particularly Down syndrome, rare genetic disorders, increasing maternal age and technological advancements. The prevalence of Down syndrome, identified as the most common chromosomal condition in the U.S. by the Centers for Disease Control and Prevention in 2023, serves as a significant driving factor for the prenatal testing market. The overall global prenatal testing market stood at $10.9 billion in 2023 and will reach $19.8 billion through 2028.
Learn More and Take Action:
Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.
Contact us today to find out more.
